AFIB News and Press, Acutus Medical Inc. From 12/29/22

CARLSBAD, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the acceptance of the AcQForce Flutter abstract titled &#x...

Acutus Medical ( NASDAQ: AFIB ) said it will get a $17M milestone payment from Medtronic ( NYSE: MDT ) as a submission for CE Mark in the EU was undertaken for its left-heart access portfolio. Acutus noted that on June 30, it completed the first closing of a previousl...

CARLSBAD, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that the Company has achiev...

CARLSBAD, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced the full commercial release of AcQMap 8.5. This next gener...

CARLSBAD, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or “the Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced receipt of a CE Mark issued...

Acutus Medical, Inc. (AFIB) Q3 2022 Earnings Conference Call November 10, 2022 04:30 PM ET Company Participants Caroline Corner - Investor Relations David Roman - President & Chief Executive Officer Takeo Mukai - Vice President, Finance & Accounting, Inte...

Acutus Medical press release ( NASDAQ: AFIB ): Q3 Non-GAAP EPS of $0.70 beats by $1.44 . Revenue of $3.6M (-21.7% Y/Y) misses by $0.04M . The company now expects FY22 revenue to be in a range from $15.5-$16.0 million, vs. consensus of $15.98M. For further...

CARLSBAD, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third ...

CARLSBAD, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that the Company has ...

Research Highlights: An analysis of more than 1.3 million Asian American adults, ages 18-44, hospitalized for atrial fibrillation, found an increase in the prevalence of five modifiable risk factors for cardiovascular disease (CVD), including obesity, Type 2 diabetes, hypertension, smoki...